Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry

Bente Glintborg; Inge Juul Sørensen; Dorte Vendelbo Jensen; Niels Steen Krogh; A. G. Loft; A. Colic; J. Espesen; J. Olsen; O. Hendricks; J. Grydehøj; I. M. J. Hansen; M. V. Sørensen; S. Chrysidis; N. Manilo; M. Klarlund; L. S. Andersen; H. Nordin; S. Kristensen; Merete Lund Hetland

Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry

Bente Glintborg, Inge Juul Sørensen, Dorte Vendelbo Jensen, Niels Steen Krogh, A. G. Loft, A. Colic, J. Espesen, J. Olsen, O. Hendricks, J. Grydehøj, I. M. J. Hansen, M. V. Sørensen, S. Chrysidis, N. Manilo, M. Klarlund, L. S. Andersen, H. Nordin, S. Kristensen, Merete Lund Hetland

Department for Rheumatology and Spine Diseases

Original language	English
Article number	OP0225
Journal	Annals of the Rheumatic Diseases
Volume	75
Issue number	Suppl. 2
Pages (from-to)	142
Number of pages	1
ISSN	0003-4967
Publication status	Published - 2016

Cite this

Glintborg, B., Sørensen, I. J., Jensen, D. V., Krogh, N. S., Loft, A. G., Colic, A., Espesen, J., Olsen, J., Hendricks, O., Grydehøj, J., Hansen, I. M. J., Sørensen, M. V., Chrysidis, S., Manilo, N., Klarlund, M., Andersen, L. S., Nordin, H., Kristensen, S., & Hetland, M. L. (2016). Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry. Annals of the Rheumatic Diseases, 75(Suppl. 2), 142. Article OP0225.

Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry. / Glintborg, Bente ; Sørensen, Inge Juul ; Jensen, Dorte Vendelbo et al.
In: Annals of the Rheumatic Diseases, Vol. 75, No. Suppl. 2, OP0225, 2016, p. 142.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Glintborg, B , Sørensen, IJ , Jensen, DV, Krogh, NS, Loft, AG, Colic, A, Espesen, J, Olsen, J, Hendricks, O, Grydehøj, J, Hansen, IMJ, Sørensen, MV, Chrysidis, S, Manilo, N, Klarlund, M, Andersen, LS, Nordin, H, Kristensen, S & Hetland, ML 2016, 'Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry', Annals of the Rheumatic Diseases, vol. 75, no. Suppl. 2, OP0225, pp. 142.

@article{9510940fc117406aa375b837401a6cef,

title = "Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry",

author = "Bente Glintborg and S{\o}rensen, {Inge Juul} and Jensen, {Dorte Vendelbo} and Krogh, {Niels Steen} and Loft, {A. G.} and A. Colic and J. Espesen and J. Olsen and O. Hendricks and J. Grydeh{\o}j and Hansen, {I. M. J.} and S{\o}rensen, {M. V.} and S. Chrysidis and N. Manilo and M. Klarlund and Andersen, {L. S.} and H. Nordin and S. Kristensen and Hetland, {Merete Lund}",

year = "2016",

language = "English",

volume = "75",

pages = "142",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 2",

}

TY - ABST

T1 - Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry

AU - Glintborg, Bente

AU - Sørensen, Inge Juul

AU - Jensen, Dorte Vendelbo

AU - Krogh, Niels Steen

AU - Loft, A. G.

AU - Colic, A.

AU - Espesen, J.

AU - Olsen, J.

AU - Hendricks, O.

AU - Grydehøj, J.

AU - Hansen, I. M. J.

AU - Sørensen, M. V.

AU - Chrysidis, S.

AU - Manilo, N.

AU - Klarlund, M.

AU - Andersen, L. S.

AU - Nordin, H.

AU - Kristensen, S.

AU - Hetland, Merete Lund

PY - 2016

Y1 - 2016

M3 - Conference abstract in journal

SN - 0003-4967

VL - 75

SP - 142

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 2

M1 - OP0225

ER -